Evidence map›Paper›PMID 39942625›Full record

ReviewMolecules (Basel, Switzerland)2025

Harnessing Nanotechnology to Enhance Essential Oil Applications.

Hossein Omidian, Luigi X Cubeddu, Erma J Gill

Abstract readReview
In one paragraph

Review in Molecules (Basel, Switzerland), 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 12 papers.

0numbers the graph read from it
0cells of the map it votes in
12citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

12 citing papers in PubMed.

  1. Article
  2. Review
  3. Essential Oils ofPathogens (Basel, Switzerland) · 2026
    Review
  4. Article
  5. Review
  6. Article
  7. Article
  8. Review
  9. Insecticidal Potential ofPlants (Basel, Switzerland) · 2025
    Article
  10. TiOMolecules (Basel, Switzerland) · 2025
    Article
  11. Nutrients · 2025
    Review
  12. Nanoemulsion ofPharmaceutics · 2025
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Hossein OmidianBarry and Judy Silverman College of Pharmacy, Nova Southeastern University, Fort Lauderdale, FL 33328, USA.ORCID 0000-0002-5637-8729
Luigi X CubedduBarry and Judy Silverman College of Pharmacy, Nova Southeastern University, Fort Lauderdale, FL 33328, USA.ORCID 0000-0002-0154-6342
Erma J GillBarry and Judy Silverman College of Pharmacy, Nova Southeastern University, Fort Lauderdale, FL 33328, USA.ORCID 0009-0009-0410-7407

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Essential oils (EOs) are versatile natural compounds with significant antimicrobial, antioxidant, antifungal, and therapeutic properties, making them valuable in industries such as food preservation, agriculture, and healthcare. However, their inherent volatility, low water solubility, and susceptibility to environmental degradation limit their direct applications. Nanotechnology offers transformative solutions to these challenges, enhancing the stability, bioavailability, and efficacy of EOs through innovative nano systems such as nano emulsions, encapsulations, and nanocomposites. This study explores the integration of nanotechnology with essential oils, emphasizing advanced preparation techniques, physicochemical properties, and diverse applications. It highlights sustainable approaches, including eco-friendly synthesis and biodegradable carriers, which align with global trends toward green chemistry. By addressing key challenges and proposing future directions, this research underscores the potential of EO nano systems to deliver multifunctional and environmentally conscious solutions for global challenges such as food security, antimicrobial resistance, and sustainable agriculture.

Indexed as

NanotechnologyOils, VolatileAnti-Infective AgentsAntioxidantsHumansAnti-Infective AgentsAntioxidantsOils, Volatileantimicrobial propertiescontrolled releaseessential oil delivery systemsnanoencapsulationsustainability

Identifiers

PMID39942625
PMCPMC11821119

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.